{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:58:58Z","timestamp":1787014738173,"version":"build-2736575974"},"reference-count":20,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,29]],"date-time":"2014-11-29T00:00:00Z","timestamp":1417219200000},"content-version":"vor","delay-in-days":819,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1111\/j.1469-0691.2011.03673.x","type":"journal-article","created":{"date-parts":[[2011,9,13]],"date-time":"2011-09-13T16:27:25Z","timestamp":1315931245000},"page":"894-900","source":"Crossref","is-referenced-by-count":34,"title":["Impact of changes in CLSI and EUCAST breakpoints for susceptibility in bloodstream infections due to extended-spectrum \u03b2-lactamase-producing Escherichia coli"],"prefix":"10.1016","volume":"18","author":[{"given":"J.","family":"Rodr\u00edguez-Ba\u00f1o","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Pic\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.D.","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"L\u00f3pez-Cerero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1.","family":"Pascual","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1469-0691.2011.03673.x_bib1","series-title":"Performance Standards for Antimicrobial Susceptibility Testing; 20th Informational Supplement (June 2010 Update) CLSI document M100\u2010S20\u2010U","author":"Clinical and Laboratory Standard Institute (CLSI)","year":"2010"},{"key":"10.1111\/j.1469-0691.2011.03673.x_bib2","series-title":"Performance Standards for Antimicrobial Susceptibility Testing; 19th Informational Supplement CLSI document M100\u2010S19","author":"Clinical and Laboratory Standard Institute (CLSI)","year":"2009"},{"key":"10.1111\/j.1469-0691.2011.03673.x_bib4","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1086\/649537","article-title":"Community\u2010onset bacteremia due to extended\u2010spectrum \u03b2\u2010lactamase\u2010producingEscherichia coli: risk factors and prognosis","volume":"50","author":"Rodr\u00edguez\u2010Ba\u00f1o","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03673.x_bib5","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1128\/JCM.02353-09","article-title":"Risk factors and prognosis of nosocomial bloodstream infections caused by extended\u2010spectrum \u03b2\u2010lactamase\u2010producingEscherichia coli","volume":"48","author":"Rodr\u00edguez\u2010Ba\u00f1o","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2011.03673.x_bib6","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1093\/jac\/dkm536","article-title":"Antimicrobial breakpoints for Gram\u2010negative aerobic bacteria based on pharmacokinetic\u2010pharmacodynamic models with Monte Carlo simulation","volume":"61","author":"Frei","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2011.03673.x_bib7","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1128\/AAC.01808-09","article-title":"Susceptibility of gram\u2010negative pathogens isolated from patients with complicated intra\u2010abdominal infections in the United States, 2007\u20102008: results of the Study for Monitoring Antimicrobial Resistance Trends (SMART)","volume":"54","author":"Hoban","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2011.03673.x_bib8","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jinf.2011.02.009","article-title":"Antimicrobial susceptibility profiles of aerobic and facultative Gram\u2010negative bacilli isolated from patients with intra\u2010abdominal infections in the Asia\u2013Pacific region according to currently established susceptibility interpretive criteria","volume":"62","author":"Chen","year":"2011","journal-title":"J Infect"},{"key":"10.1111\/j.1469-0691.2011.03673.x_bib9","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s10096-010-1066-0","article-title":"Antimicrobial susceptibility of intra\u2010abdominal Gram\u2010negative bacilli from Europe: SMART Europe 2008","volume":"30","author":"Hawser","year":"2011","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03673.x_bib10","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1128\/AAC.00265-10","volume":"54","author":"Hawser","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2011.03673.x_bib11","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1086\/653932","article-title":"Escherichia coli sequence type ST131 as the major cause of serious multidrug\u2010resistantE. coli infections in the United States","volume":"51","author":"Johnson","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03673.x_bib12","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3201\/eid1402.070350","article-title":"Dissemination of clonally relatedEscherichia coli strains expressing extended\u2010spectrum \u03b2\u2010lactamase CTX\u2010M\u201015","volume":"14","author":"Coque","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03673.x_bib13","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1128\/AAC.00247-09","article-title":"Molecular characteristics of extended\u2010spectrum\u2010\u03b2\u2010lactamase\u2010producingEscherichia coli isolates causing bacteremia in the Calgary Health Region from 2000 to 2007: emergence of clone ST131 as a cause of community\u2010acquired infections","volume":"53","author":"Pitout","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2011.03673.x_bib14","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1128\/CMR.18.4.657-686.2005","article-title":"Extended\u2010spectrum \u03b2\u2010lactamases: a clinical update","volume":"18","author":"Paterson","year":"2005","journal-title":"Clin Microbiol Rev"},{"issue":"Suppl. 6","key":"10.1111\/j.1469-0691.2011.03673.x_bib15","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1469-0691.2005.01265.x","article-title":"Treatment of infections with ESBL\u2010producing organisms: pharmacokinetic and pharmacodynamic considerations","volume":"11","author":"Andes","year":"2005","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl. 1","key":"10.1111\/j.1469-0691.2011.03673.x_bib16","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1469-0691.2007.01859.x","article-title":"Breakpoints for extended\u2010spectrum \u03b2\u2010lactamase\u2010producing Enterobacteriaceae: pharmacokinetic\/pharmacodynamic considerations","volume":"14","author":"MacGowan","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1469-0691.2011.03673.x_bib17","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.diagmicrobio.2006.06.015","article-title":"Outcome of cephalosporin treatment of bacteremia due to CTX\u2010M type extended\u2010spectrum \u03b2\u2010lactamase\u2010producingEscherichia coli","volume":"56","author":"Bin","year":"2006","journal-title":"Diag Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03673.x_bib18","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1128\/JCM.42.1.269-275.2004","article-title":"Effects of inoculum and \u03b2\u2010lactamase activity in AmpC\u2010 and extended\u2010spectrum \u03b2\u2010lactamase (ESBL)\u2010producingEscherichia coli andKlebsiella pneumoniae clinical isolates tested by using NCCLS ESBL methodology","volume":"42","author":"Queenan","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2011.03673.x_bib19","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1128\/AAC.43.2.393","article-title":"Diversification ofEscherichia coli expressing an SHV\u2010type extended\u2010spectrum \u03b2\u2010lactamase (ESBL) during a hospital outbreak: emergence of an ESBL\u2010hyperproducing strain resistant to expanded\u2010spectrum cephalosporins","volume":"43","author":"Pa\u0142ucha","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl. 1","key":"10.1111\/j.1469-0691.2011.03673.x_bib20","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1469-0691.2007.01860.x","article-title":"Extended\u2010spectrum \u03b2\u2010lactamases and the permeability barrier","volume":"14","author":"Mart\u00ednez\u2010Mart\u00ednez","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1469-0691.2011.03673.x_bib21","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1586\/14787210.6.5.671","article-title":"Clinical significance of extended\u2010spectrum \u03b2\u2010lactamases","volume":"6","author":"Rodr\u00edguez\u2010Ba\u00f1o","year":"2008","journal-title":"Expert Rev Anti Infect Therapy"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14610697?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14610697?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,15]],"date-time":"2019-06-15T09:00:58Z","timestamp":1560589258000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X14610697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":20,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S1198743X14610697"],"URL":"https:\/\/doi.org\/10.1111\/j.1469-0691.2011.03673.x","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}